Clinuvel Pharmaceuticals Limited (ASX: CUV)

Clinuvel Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	35.2	35.2	31.89	121.51	82.69	66.75
Short-Term Investments	148.67	148.67	124.92	-	-	-
Cash & Short-Term Investments	183.87	183.87	156.81	121.51	82.69	66.75
Cash Growth	17.25%	17.25%	29.05%	46.94%	23.89%	22.99%
Accounts Receivable	25.01	25.01	20.64	15.9	15.81	6.35
Other Receivables	1.23	1.23	1.57	0.3	0.28	0.26
Receivables	26.24	26.24	22.21	16.2	16.09	6.61
Inventory	10.63	10.63	9.52	1.83	3.19	1.29
Prepaid Expenses	-	-	-	1.04	0.88	0.51
Other Current Assets	1.33	1.33	1.07	-	-	-
Total Current Assets	222.06	222.06	189.62	140.58	102.85	75.16
Property, Plant & Equipment	7.72	7.72	2.85	2.7	2.6	2.39
Long-Term Investments	0.13	0.13	-	-	-	-
Goodwill	-	-	-	0.19	0.19	0.19
Other Intangible Assets	0.19	0.19	0.19	-	-	-
Long-Term Deferred Tax Assets	1.02	1.02	1.06	0.48	2.93	3.81
Total Assets	231.12	231.12	193.71	143.95	108.57	81.54
Accounts Payable	2.35	2.35	2.79	0.26	4.66	1.43
Accrued Expenses	1.88	1.88	1.45	2.86	3.7	3.28
Current Portion of Leases	0.37	0.37	0.3	0.32	0.26	0.21
Current Income Taxes Payable	15.85	15.85	16.09	7.28	0.1	-
Other Current Liabilities	4.76	4.76	4.86	3.02	-	3.34
Total Current Liabilities	25.21	25.21	25.49	13.73	8.71	8.26
Long-Term Leases	0.51	0.51	0.7	0.94	1.05	1.11
Long-Term Deferred Tax Liabilities	2.23	2.23	2.76	3.62	-	-
Other Long-Term Liabilities	0.08	0.08	0.07	0.07	0.06	0.1
Total Liabilities	28.11	28.11	29.08	18.39	9.83	9.48
Common Stock	168.8	168.8	151.85	151.85	151.85	151.85
Retained Earnings	29.96	29.96	-9.77	-38.4	-58.13	-81.63
Comprehensive Income & Other	4.25	4.25	22.56	12.11	5.02	1.85
Total Common Equity	203.01	203.01	164.63	125.56	98.74	72.07
Shareholders' Equity	203.01	203.01	164.63	125.56	98.74	72.07
Total Liabilities & Equity	231.12	231.12	193.71	143.95	108.57	81.54
Total Debt	0.88	0.88	1	1.26	1.3	1.32
Net Cash (Debt)	182.99	182.99	155.81	120.25	81.39	65.43
Net Cash Growth	17.44%	17.44%	29.57%	47.75%	24.39%	21.53%
Net Cash Per Share	3.59	3.59	3.01	2.32	1.59	1.30
Filing Date Shares Outstanding	50.08	50.08	49.41	49.41	49.41	49.41
Total Common Shares Outstanding	50.08	50.08	49.41	49.41	49.41	49.41
Working Capital	196.85	196.85	164.12	126.85	94.14	66.89
Book Value Per Share	4.05	4.05	3.33	2.54	2.00	1.46
Tangible Book Value	202.83	202.83	164.45	125.37	98.55	71.88
Tangible Book Value Per Share	4.05	4.05	3.33	2.54	1.99	1.45
Land	0.35	0.35	-	-	-	-
Buildings	4.62	4.62	-	-	-	-
Machinery	1.94	1.94	1.53	1.33	0.82	0.68
Leasehold Improvements	1.99	1.99	1.89	1.25	1.25	0.76

Source: S&P Capital IQ. Standard template. Financial Sources.